1-3 of 3
Lawrence David Kaplan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination of Glofitamab with Pirtobrutinib in BTK Inhibitor (BTKi)-Naive or Btki-Intolerant Patients with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): A Multicenter Phase 2 Study of the University of California Hematologic Malignancies Consortium

Madhav R Seshadri, Chiung-Yu Huang, Hildy Donner, William B. Pearse, Patricia A. Young, Monica Mead, Naseem S. Esteghamat, Christine Thacker, Lauren Nguyen, Weiyun Ai, Michael A Spinner, Lawrence David Kaplan, Charalambos Andreadis
Journal: Blood
Blood (2024) 144 (Supplement 1): 3042.3.
https://doi.org/10.1182/blood-2024-209493
Published: 2024
Journal Articles

Development of Cytokine Release Syndrome Is Associated with Superior Progression-Free Survival in DLBCL Patients Receiving Axi-Cel or Liso-Cel

Matthew A Karr, Michael A Spinner, Sarah Wang, Charalambos Andreadis, Madhav R Seshadri, Lawrence David Kaplan, Weiyun Ai, Siobhan LaRue
Journal: Blood
Blood (2023) 142 (Supplement 1): 7344.
https://doi.org/10.1182/blood-2023-173885
Published: 2023
Journal Articles

Ki-67 Expression of 50% Is the Optimal Cut-Off to Predict Survival Outcomes in Mantle Cell Lymphoma (MCL): A Pooled Analysis from CALGB 50403 (Alliance) and MCL Real-World Study Cohort

Narendranath Epperla, Jeffrey M. Switchenko, Susan M. Geyer, Veronika Bachanova, Stefan K. Barta, Alexey Danilov, Natalie S. Grover, Reem Karmali, Brian T. Hill, Nilanjan Ghosh, Timothy S. Fenske, Peter Martin, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Eric D. Hsi, Kami J. Maddocks, Kristie A. Blum, Thomas M. Habermann, Matthew J. Maurer, Lawrence David Kaplan, Nancy L. Bartlett, John P. Leonard, Jonathon B. Cohen
Journal: Blood
Blood (2023) 142 (Supplement 1): 380.
https://doi.org/10.1182/blood-2023-189505
Published: 2023